153 related articles for article (PubMed ID: 15616344)
1. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal.
Conceição T; Brízio A; Duarte A; Lito LM; Cristino JM; Salgado MJ
Antimicrob Agents Chemother; 2005 Jan; 49(1):477-8. PubMed ID: 15616344
[No Abstract] [Full Text] [Related]
2. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
[TBL] [Abstract][Full Text] [Related]
3. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM
Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304
[TBL] [Abstract][Full Text] [Related]
4. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.
Kristóf K; Tóth A; Damjanova I; Jánvári L; Konkoly-Thege M; Kocsis B; Koncan R; Cornaglia G; Szego E; Nagy K; Szabó D
J Antimicrob Chemother; 2010 Jun; 65(6):1303-5. PubMed ID: 20410063
[No Abstract] [Full Text] [Related]
5. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases.
Essack SY; Hall LM; Livermore DM
Int J Antimicrob Agents; 2004 Apr; 23(4):398-400. PubMed ID: 15081091
[TBL] [Abstract][Full Text] [Related]
6. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
7. New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae.
Soge OO; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Nov; 58(5):1048-53. PubMed ID: 16997844
[TBL] [Abstract][Full Text] [Related]
8. ACT-3, a novel plasmid-encoded class C beta-lactamase in a Klebsiella pneumoniae isolate from China.
Chen Y; Cheng J; Wang Q; Ye Y; Li JB; Zhang XJ
Int J Antimicrob Agents; 2009 Jan; 33(1):95-6. PubMed ID: 18789849
[No Abstract] [Full Text] [Related]
9. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
10. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
11. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R
Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867
[TBL] [Abstract][Full Text] [Related]
12. Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
Papagiannitsis CC; Tryfinopoulou K; Giakkoupi P; Pappa O; Polemis M; Tzelepi E; Tzouvelekis LS; ; Vatopoulos AC
Int J Antimicrob Agents; 2012 Feb; 39(2):178-80. PubMed ID: 22104281
[No Abstract] [Full Text] [Related]
13. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
14. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
16. Emergence of OXA-48-producing Enterobacteriaceae in Switzerland.
Potron A; Schrenzel J; Poirel L; Renzi G; Cherkaoui A; Nordmann P
Int J Antimicrob Agents; 2012 Dec; 40(6):563-4. PubMed ID: 23040008
[No Abstract] [Full Text] [Related]
17. Increased resistance to beta-lactams in a Klebsiella pneumoniae strain: role of a deletion downstream of the Pribnow box in the blaSHV-1 promoter.
Corvec S; Caroff N; Cosano D; Dauvergne S; Drugeon H; Reynaud A
Int J Antimicrob Agents; 2006 Oct; 28(4):308-12. PubMed ID: 16956751
[TBL] [Abstract][Full Text] [Related]
18. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.
Nelson EC; Segal H; Elisha BG
J Antimicrob Chemother; 2003 Dec; 52(6):899-903. PubMed ID: 14613957
[TBL] [Abstract][Full Text] [Related]
20. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
Ensor VM; Shahid M; Evans JT; Hawkey PM
J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
